An extracellular stochastic model of early HIV infection and the formulation of optimal treatment policy

Chemical Engineering Science

Volumn 63, Issue 17, 2008, Pages 4361-4372

  Khalili, Samira ^a   Armaou, Antonios ^a  

^a The Pennsylvania State University   (United States)

Author keywords

Biological and biomolecular engineering; Biomedical engineering; Chemotherapy; HIV; Mathematical modeling; Optimization

Indexed keywords

BIOMEDICAL ENGINEERING; CHEMOTHERAPY; DISEASES; DRUG DOSAGE; DRUG INTERACTIONS; MATHEMATICAL MODELS; OPTIMIZATION; PATIENT TREATMENT; PROBABILITY; STOCHASTIC SYSTEMS; VIRUSES;

BIOMOLECULAR ENGINEERING; EXTRACELLULAR; HIV INFECTION; HUMAN IMMUNODEFICIENCY VIRUS; OPTIMAL TREATMENT; OPTIMIZATION PROBLEMS; STOCHASTIC SIMULATIONS; TOXIC SIDE EFFECTS;

STOCHASTIC MODELS;

EID: 54249129265     PISSN: 00092509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ces.2008.05.033     Document Type: Article

References (53)

1. Blake, M.E., 2007. Vaccination and enrollment are discontinued in phase II trials of Merck's investigational HIV vaccine candidate. Merck News Release.
2. Cardo, D., et al., 1999. HIV postexposure prophylaxis registry. HIV Pep Registry Final Report.
3. Carlos, V., Garcia, M.R., Banga, J.R., Alonso, A.A., 2006. Stabilization of inhomogeneous patterns in a diffusion reaction system under structural and parametric uncertainties. Journal of Theoretical Biology 241, 295-306.
4. Coffin, J.M., Hughes, S.H., Varmus, H.E., 1997. Retroviruses. Cold Spring Harbor Laboratory Press.
5. Culshaw, R.V., Ruan, S., Spiteri, R.J., 2004. Optimal HIV treatment by maximizing immune response. Journal of Mathematical Biology 48, 545-562.
6. Deisenhammer, S., Radon, K., Nowak, D., Reichert, J., 2006. Needlestick injuries during medical training. Journal of Hospital Infection 63, 263-267.
7. Dixit, N.M., Markowitz, M., Ho, D.D., Perelson, A.S., 2004. Estimates of intracellular delay and average and drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy. Antiviral Therapy 9, 237-246.
8. El-Farra, N.H., Gani, A., Christofides, P.D., 2005. Analysis of mode transitions in biological networks. A.I.Ch.E. Journal 51, 2220-2234.
9. El Safadi, Y., Vivet-Boudou, V., Marquet, R., 2007. HIV-1 reverse transcriptase inhibitors. Applied Microbiology and Biotechnology 75, 723-737.
10. Fichthorn, K.A., Weinberg, W.H., 1991. Theoretical foundations of dynamical Monte Carlo simulations. Journal of Chemical Physics 95, 1090-1096.
11. Gillespie, D.T., 1976. A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. Journal of Computational Physics 22, 403-434.
12. Gillespie, D.T., Petzold, L.R., 2003. Improved leap-size selection for accelerated stochastic simulation. Journal of Chemical Physics 119 (16), 8229-8234.
13. Hamlyn, E., Easterbrook, P., 2007. Occupational exposure to HIV and the use of post-exposure prophylaxis. Occupational Medicine 57, 329-336.
14. Haseltine, E.L., Rawlings, J.B., Yin, J., 2004. Dynamics of viral infections: incorporating both the intracellular and extracellular levels. Computers and Chemical Engineering 29, 675-686.
15. Heffernan, J.M., Wahl, L.M., 2005. Monte Carlo estimates of natural variation in HIV-1 infection. Journal of Theoretical Biology 236, 137-153.
16. Heffernan, J.M., Wahl, L.M., 2006. Natural variation in HIV-1 infection: Monte Carlo estimates that include CD8 effector cells. Journal of Theoretical Biology 243, 191-204.
17. Henderson, D.K., 2001. HIV postexposure prophylaxis in the 21st century. Emerging Infectious Diseases 7 (2), 254-258.
18. Hsu, A., Granneman, G., Leonard, J., Witt, G., Locke, C., Denissen, J., Molla, A., Valdes, J., Smith, J., Erdman, K., Lyons, N., Niu, P., Decourt, J., Fourtillan, J., Girault, J., 1997. Multiple dose pharmacokinetics of ritonavir in HIV infected subjects. Antimicrobial Agents and Chemotherapy 41.
19. Hughes, J.H., 2005. Updated U.S. public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. Morbidity and Mortality Weekly Report 50 (RR-11).
20. Joly, M., Pinto, J.M., 2006. Role of mathematical modeling on the optimal control of HIV-1 pathogenesis. A.I.Ch.E. Journal 52, 856-884.
21. Kamina, A., Makuch, R.W., Zhao, H., 2001. A stochastic modeling of early HIV-1 population dynamics. Mathematical Biosciences 170, 187-198.
22. Kelley, C.T., 1999. Iterative Methods for Optimization. SIAM, Philadelphia, PA, USA.
23. Kevrekidis, I.G., Gear, C.W., Hyman, J.M., Kevrekidis, P.C., Runborg, O., Theodoropoulos, K., 2003. Equation-free multiscale computation: enabling microscopic simulators to perform system-level tasks. Communication in Mathematical Sciences 1, 715-762.
24. Khalili, S., Armaou, A., 2006. Sensitivity analysis of HIV infection response to treatment. In: Proceedings of the 45th IEEE Conference on Decision and Control, San Diego, CA, pp. 2069-2075
25. Khalili, S., Armaou, A., 2008. Sensitivity analysis of HIV infection response to treatment via stochastic modeling. Chemical Engineering Science 63.
26. Kirschner, D., Lenhart, S., Serbin, S., 1997. Optimal control of the chemotherapy of HIV. Journal of Mathematical Biology 35, 775-792.
27. Lewis, R.M., Torczon, V., 2000. Pattern search algorithms for linearly constrained minimization. SIAM Journal on Optimization 10, 917-947.
28. Lister, S., 2005. Secret of the morning-after pill that gives protection against HIV. Times On Line 4.
29. Little, S.J., et al., 1999. Reduced antiretroviral drug susceptibility among patients with primary HIV infection. Journal of the American Medical Association 282, 1142-1149.
30. Merck, 2007. HIV vaccine failure prompts merck to halt trial. Nature 449, 390.
31. Merrill, S.J., 2005. The stochastic dance of early HIV infection. Journal of Computational and Applied Mathematics 184, 242-257.
32. Panlilio, A.D., Cardo, D.M., Grohskopf, L.A., Heneine, W., Ross, C.S., 2005. Updated U.S. public health service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. Morbidity and Mortality Weekly Report 54 (RR-9).
33. Perelson, A.S., Essunger, P., 1997. Dynamics of HIV-1 and CD4+ lymphocytes in vivo. AIDS 11, S17-S24.
34. Perelson, A.S., Nelson, P.W., 1999. Mathematical analysis of HIV-1 dynamics in vivo. SIAM Review 41 (1), 3-44.
35. Pillay, D., 2001. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ 322, 1087-1088.
36. Raimondeau, S., Vlachos, D.G., 2002. Recent developments on multiscale, hierarchical modeling of chemical reactors. Chemical Engineering Journal 90, 3-23.
37. Rao, C.V., Arkin, A.P., 2003. Stochastic chemical kinetics and the quasi steady state assumption: application to the Gillespie algorithm. Journal of Chemical Physics 118 (11), 4999-5010.
38. Reddy, B., Yin, J., 1999. Quantitative intracellular kinetics of HIV type 1. AIDS Research and Human Retroviruses 15, 273-283.
39. Salis, H., Kaznessis, Y., 2005. Accurate hybrid stochastic simulation of a system of coupled chemical or biochemical reactions. Journal of Chemical Physics 122, 054103,1-054103,13.
40. Salis, H., Sotiropoulos, V., Kaznessis, Y., 2006. Multiscale hy3s: hybrid stochastic simulation for supercomputers. BMC Bioinformatics 7.
41. Samant, A., Vlachos, D.G., 2005. Overcoming stiffness in stochastic simulation stemmimg from partial equilibrium: a multiscale Monte Carlo Algorithm. Journal of Chemical Physics 123, 2797-2799.
42. Siettos, C.I., Armaou, A., Makeev, A.C., Kevrekidis, I.G., 2003. Microscopic/stochastic timesteppers and coarse control: a kinetic Monte Carlo example. A.I.Ch.E. Journal 49, 1922-1926.
43. Snedecor, S.J., 2003. Comparison of three kinetic models of HIV-1 infection: implications for optimization of treatment. Journal of Theoretical Biology 221, 519-541.
44. Srivastava, R., You, L., Summers, J., Yin, J., 2002. Stochastic vs. deterministic modeling of intracellular viral kinetics. Journal of Theoretical Biology 218, 309-321.
45. Stafford, M.A., Perelson, A.S., 2000. Modeling plasma virus concentration during primary HIV infection. Journal of Theoretical Biology 203, 285-301.
46. Stephanopoulos, G., Dyer, M., Karsligil, O., 1997. Multiscale modeling, estimation and control of processing systems. Computers and Chemical Engineering 21, S797-S803.
47. Tan, W., Wu, H., 1998. Stochastic modeling of the dynamics of CD4 T-cell infection by HIV-1 and some Monte Carlo studies. Mathematical Biosciences 147, 173-205.
48. Tuckwell, H.C., Le Corfec, E., 1998. A stochastic model for early HIV-1 population dynamics. Journal of Theoretical Biology 195, 451-463.
49. Vergu, E., Golmard, J.L., 2005. A modeling approach to the impact of HIV mutations on the immune system. Computers in Biology and Medicine 35, 1-24.
50. Walensky, R., Goldie, S., Sax, P., Weinstein, M., Paltiel, A., Kimmel, A,, Seage, G., Losina, E., Zhang, H., Islam, R., Freedberg, K., 2002. Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy. Journal of Acquired Immunodeficiency Syndrome 31, 27-37.
51. Xia, X., 2003. Estimation of HIV/AIDS parameters. Automatica 39, 1983-1988.
52. Yerly, S., 1999. Transmission of antiretroviral-drug-resistant HIV-1 variants. The Lancet 354, 729-733.
53. Zurakowski, R., Teel, A.R., 2006. A model predictive control based scheduling method for HIV therapy. Journal of Theoretical Biology 238, 368-382.